Does the media prefer OM or CLPT?

In the previous week, Outset Medical had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for Outset Medical and 2 mentions for ClearPoint Neuro. Outset Medical's average media sentiment score of -0.05 beat ClearPoint Neuro's score of -0.07 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer OM or ELMD?

In the previous week, Outset Medical had 2 more articles in the media than Electromed. MarketBeat recorded 4 mentions for Outset Medical and 2 mentions for Electromed. Electromed's average media sentiment score of 1.00 beat Outset Medical's score of -0.05 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SI or OM?

In the previous week, Outset Medical had 3 more articles in the media than Shoulder Innovations. MarketBeat recorded 4 mentions for Outset Medical and 1 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.50 beat Outset Medical's score of -0.05 indicating that Shoulder Innovations is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Outset Medical (OM) Competitors

$4.59 +0.27 (+6.34%)

As of 10:35 AM Eastern

Compare

OM vs. CLPT, DCTH, CV, ELMD, and SI

Should you buy Outset Medical stock or one of its competitors? MarketBeat compares Outset Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Outset Medical include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), CapsoVision (CV), Electromed (ELMD), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry.

How does Outset Medical compare to ClearPoint Neuro?

Outset Medical (NASDAQ:OM) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

Outset Medical has a net margin of -63.65% compared to ClearPoint Neuro's net margin of -71.57%. Outset Medical's return on equity of -56.13% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

30.1% of ClearPoint Neuro shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Outset Medical has a beta of 1.95, suggesting that its share price is 95% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, suggesting that its share price is 31% more volatile than the broader market.

In the previous week, Outset Medical had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 4 mentions for Outset Medical and 2 mentions for ClearPoint Neuro. Outset Medical's average media sentiment score of -0.05 beat ClearPoint Neuro's score of -0.07 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ClearPoint Neuro	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Outset Medical currently has a consensus target price of $10.00, indicating a potential upside of 117.68%. ClearPoint Neuro has a consensus target price of $18.00, indicating a potential upside of 30.68%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Outset Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

ClearPoint Neuro has lower revenue, but higher earnings than Outset Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.71	-$81.65M	-$4.16	N/A
ClearPoint Neuro	$36.97M	11.17	-$25.54M	-$1.01	N/A

Summary

Outset Medical beats ClearPoint Neuro on 11 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Delcath Systems has a net margin of 0.62% compared to Outset Medical's net margin of -63.65%. Delcath Systems' return on equity of 0.51% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Outset Medical	-63.65%	-56.13%	-27.45%

Delcath Systems currently has a consensus target price of $22.50, suggesting a potential upside of 91.70%. Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 117.68%. Given Outset Medical's higher possible upside, analysts clearly believe Outset Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Delcath Systems has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

In the previous week, Outset Medical had 4 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 beat Outset Medical's score of -0.05 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Neutral
Outset Medical	Neutral

Delcath Systems has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.75	$2.70M	$0.01	1,173.70
Outset Medical	$119.48M	0.71	-$81.65M	-$4.16	N/A

Summary

Delcath Systems beats Outset Medical on 12 of the 16 factors compared between the two stocks.

How does Outset Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Outset Medical (NASDAQ:OM) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Outset Medical has a net margin of -63.65% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Outset Medical	-63.65%	-56.13%	-27.45%

CapsoVision currently has a consensus target price of $8.50, indicating a potential upside of 16.84%. Outset Medical has a consensus target price of $10.00, indicating a potential upside of 117.68%. Given Outset Medical's higher probable upside, analysts plainly believe Outset Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Outset Medical had 4 more articles in the media than CapsoVision. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.00 beat Outset Medical's score of -0.05 indicating that CapsoVision is being referred to more favorably in the media.

Company	Overall Sentiment
CapsoVision	Neutral
Outset Medical	Neutral

CapsoVision has higher earnings, but lower revenue than Outset Medical. CapsoVision is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	26.82	-$25.32M	-$2.34	N/A
Outset Medical	$119.48M	0.71	-$81.65M	-$4.16	N/A

Summary

CapsoVision and Outset Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Outset Medical compare to Electromed?

Outset Medical (NASDAQ:OM) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Electromed has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.71	-$81.65M	-$4.16	N/A
Electromed	$71.75M	4.25	$5.15M	$1.17	31.50

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 117.68%. Electromed has a consensus target price of $37.50, suggesting a potential upside of 1.75%. Given Outset Medical's higher probable upside, equities analysts plainly believe Outset Medical is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Electromed has a net margin of 11.34% compared to Outset Medical's net margin of -63.65%. Electromed's return on equity of 15.71% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Electromed	11.34%	15.71%	13.37%

Outset Medical has a beta of 1.95, meaning that its share price is 95% more volatile than the broader market. Comparatively, Electromed has a beta of 0.53, meaning that its share price is 47% less volatile than the broader market.

40.8% of Electromed shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Outset Medical had 2 more articles in the media than Electromed. MarketBeat recorded 4 mentions for Outset Medical and 2 mentions for Electromed. Electromed's average media sentiment score of 1.00 beat Outset Medical's score of -0.05 indicating that Electromed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Electromed	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Electromed beats Outset Medical on 12 of the 16 factors compared between the two stocks.

How does Outset Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Outset Medical has a net margin of -63.65% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
Outset Medical	-63.65%	-56.13%	-27.45%

In the previous week, Outset Medical had 3 more articles in the media than Shoulder Innovations. MarketBeat recorded 4 mentions for Outset Medical and 1 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.50 beat Outset Medical's score of -0.05 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Shoulder Innovations has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	6.34	-$40.36M	-$166.96	N/A
Outset Medical	$119.48M	0.71	-$81.65M	-$4.16	N/A

Shoulder Innovations currently has a consensus price target of $21.00, indicating a potential upside of 45.13%. Outset Medical has a consensus price target of $10.00, indicating a potential upside of 117.68%. Given Outset Medical's higher possible upside, analysts clearly believe Outset Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Shoulder Innovations beats Outset Medical on 8 of the 13 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$85.28M	$1.56B	$6.47B	$12.16B
Dividend Yield	N/A	N/A	2.67%	5.58%
P/E Ratio	-1.11	78.17	23.96	24.11
Price / Sales	0.71	22.14	535.67	120.23
Price / Cash	N/A	22.89	26.99	37.25
Price / Book	0.66	4.90	10.54	6.88
Net Income	-$81.65M	-$54.76M	$3.56B	$337.04M
7 Day Performance	-9.39%	-2.99%	1.51%	-0.83%
1 Month Performance	24.50%	2.88%	4.47%	3.46%
1 Year Performance	-78.37%	-8.40%	23.87%	27.46%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	2.5548 of 5 stars	$4.59 +6.3%	$10.00 +117.7%	-79.4%	$85.28M	$119.48M	N/A	520
CLPT ClearPoint Neuro	2.8913 of 5 stars	$12.37 -2.1%	$18.00 +45.5%	-3.9%	$370.98M	$40.61M	N/A	110
DCTH Delcath Systems	1.9682 of 5 stars	$10.53 -0.7%	$22.50 +113.7%	-33.2%	$363.52M	$90.44M	1,053.00	60
CV CapsoVision	1.163 of 5 stars	$6.85 -0.7%	$8.50 +24.1%	N/A	$342.25M	$13.56M	N/A	90	Positive News
ELMD Electromed	1.3943 of 5 stars	$36.72 +0.3%	$37.50 +2.1%	+77.0%	$304.08M	$71.75M	48.97	160	Positive News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. CLPT, DCTH, CV, ELMD, and SI

How does Outset Medical compare to ClearPoint Neuro?

Summary

How does Outset Medical compare to Delcath Systems?

Summary

How does Outset Medical compare to CapsoVision?

Summary

How does Outset Medical compare to Electromed?

Summary

How does Outset Medical compare to Shoulder Innovations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. CLPT, DCTH, CV, ELMD, and SI

How does Outset Medical compare to ClearPoint Neuro?

Is OM or CLPT more profitable?

Do institutionals and insiders believe in OM or CLPT?

Which has more volatility & risk, OM or CLPT?

Does the media prefer OM or CLPT?

Do analysts prefer OM or CLPT?

Which has stronger earnings & valuation, OM or CLPT?

Summary

How does Outset Medical compare to Delcath Systems?

Is DCTH or OM more profitable?

Do analysts prefer DCTH or OM?

Do institutionals & insiders hold more shares of DCTH or OM?

Which has more volatility and risk, DCTH or OM?

Does the media refer more to DCTH or OM?

Which has stronger earnings & valuation, DCTH or OM?

Summary

How does Outset Medical compare to CapsoVision?

Is CV or OM more profitable?

Do analysts prefer CV or OM?

Does the media favor CV or OM?

Which has higher earnings and valuation, CV or OM?

Summary

How does Outset Medical compare to Electromed?

Which has preferable valuation & earnings, OM or ELMD?

Do analysts recommend OM or ELMD?

Is OM or ELMD more profitable?

Which has more risk & volatility, OM or ELMD?

Do insiders and institutionals believe in OM or ELMD?

Does the media prefer OM or ELMD?

Summary

How does Outset Medical compare to Shoulder Innovations?

Is SI or OM more profitable?

Does the media favor SI or OM?

Which has better earnings & valuation, SI or OM?

Do analysts prefer SI or OM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools